Dipeptidyl peptidase
From Proteopedia
(Difference between revisions)
Line 20: | Line 20: | ||
== Structural highlights == | == Structural highlights == | ||
- | Human DPP-I contains 3 chains. <scene name='43/433126/Cv/4'>Light</scene> and <scene name='43/433126/Cv/5'>heavy chains forming the catalytic site</scene> and a <scene name='43/433126/Cv/6'>third chain including the exclusion domain</scene> which is responsible of the exopeptidase activity of DPP-I by partially blocking the active site cleft. The inhibitors binds to a Cys residue at the active site. <ref>PMID:24592859</ref> | + | Human DPP-I contains 3 chains. <scene name='43/433126/Cv/4'>Light</scene> and <scene name='43/433126/Cv/5'>heavy chains forming the catalytic site</scene> and a <scene name='43/433126/Cv/6'>third chain including the exclusion domain</scene> which is responsible of the exopeptidase activity of DPP-I by partially blocking the active site cleft. The <scene name='43/433126/Cv/7'>inhibitors binds to a Cys residue at the active site</scene>. <ref>PMID:24592859</ref> |
</StructureSection> | </StructureSection> | ||
== 3D Structures of Dipeptidyl peptidase == | == 3D Structures of Dipeptidyl peptidase == |
Revision as of 14:02, 30 December 2015
|
3D Structures of Dipeptidyl peptidase
Updated on 30-December-2015
References
- ↑ Pro B, Dang NH. CD26/dipeptidyl peptidase IV and its role in cancer. Histol Histopathol. 2004 Oct;19(4):1345-51. PMID:15375776
- ↑ Barnett A. DPP-4 inhibitors and their potential role in the management of type 2 diabetes. Int J Clin Pract. 2006 Nov;60(11):1454-70. PMID:17073841 doi:10.1111/j.1742-1241.2006.01178.x
- ↑ Itou M, Kawaguchi T, Taniguchi E, Sata M. Dipeptidyl peptidase-4: a key player in chronic liver disease. World J Gastroenterol. 2013 Apr 21;19(15):2298-306. doi:, 10.3748/wjg.v19.i15.2298. PMID:23613622 doi:http://dx.doi.org/10.3748/wjg.v19.i15.2298
- ↑ Furber M, Tiden AK, Gardiner P, Mete A, Ford R, Millichip I, Stein L, Mather A, Kinchin E, Luckhurst C, Barber S, Cage P, Sanganee H, Austin R, Chohan K, Beri R, Thong B, Wallace A, Oreffo V, Hutchinson R, Harper S, Debreczeni J, Breed J, Wissler L, Edman K. Cathepsin C Inhibitors: Property Optimization and Identification of a Clinical Candidate. J Med Chem. 2014 Mar 14. PMID:24592859 doi:http://dx.doi.org/10.1021/jm401705g